A researcher of the Atomic Energy Commission (CEA) checks an Ebola diagnostic test in Marcoule, November 3, 2014. Researchers of Life Science Division (DSV) developed a rapid diagnostic test for the Ebola virus, named eZyscreen, used on the field without special equipment, from a drop of blood, plasma or urine and able to give an answer in less than 15 minutes for any patient with symptoms of the disease. A prototype will be available soon to allow clinical validation in the field, before the industrialization phase and production by the French company VEDALAB, European leader of rapid tests. REUTERS/Jean-Paul Pelissier (FRANCE - Tags: HEALTH SOCIETY SCIENCE TECHNOLOGY DISASTER) 

A researcher of the Atomic Energy Commission (CEA) checks an Ebola diagnostic test in Marcoule, November 3, 2014. Researchers of Life Science Division (DSV) developed a rapid diagnostic test for the Ebola virus, named eZyscreen, used on the field without special equipment, from a drop of blood, plasma or urine and able to give an answer in less than 15 minutes for any patient with symptoms of the disease. A prototype will be available soon to allow clinical validation in the field, before the industrialization phase and production by the French company VEDALAB, European leader of rapid tests. REUTERS/Jean-Paul Pelissier (FRANCE - Tags: HEALTH SOCIETY SCIENCE TECHNOLOGY DISASTER) 

A researcher of the Atomic Energy Commission (CEA) checks an Ebola diagnostic test in Marcoule, November 3, 2014. Researchers of Life Science Division (DSV) developed a rapid diagnostic test for the Ebola virus, named eZyscreen, used on the field without special equipment, from a drop of blood, plasma or urine and able to give an answer in less than 15 minutes for any patient with symptoms of the disease. A prototype will be available soon to allow clinical validation in the field, before the industrialization phase and production by the French company VEDALAB, European leader of rapid tests. REUTERS/Jean-Paul Pelissier (FRANCE - Tags: HEALTH SOCIETY SCIENCE TECHNOLOGY DISASTER) 

A researcher of the Atomic Energy Commission (CEA) checks an Ebola diagnostic test in Marcoule, November 3, 2014. Researchers of Life Science Division (DSV) developed a rapid diagnostic test for the Ebola virus, named eZyscreen, used on the field without special equipment, from a drop of blood, plasma or urine and able to give an answer in less than 15 minutes for any patient with symptoms of the disease. A prototype will be available soon to allow clinical validation in the field, before the industrialization phase and production by the French company VEDALAB, European leader of rapid tests. REUTERS/Jean-Paul Pelissier (FRANCE - Tags: HEALTH SOCIETY SCIENCE TECHNOLOGY DISASTER) 

A researcher of the Atomic Energy Commission (CEA) checks an Ebola diagnostic test in Marcoule, November 3, 2014. Researchers of Life Science Division (DSV) developed a rapid diagnostic test for the Ebola virus, named eZyscreen, used on the field without special equipment, from a drop of blood, plasma or urine and able to give an answer in less than 15 minutes for any patient with symptoms of the disease. A prototype will be available soon to allow clinical validation in the field, before the industrialization phase and production by the French company VEDALAB, European leader of rapid tests. REUTERS/Jean-Paul Pelissier (FRANCE - Tags: HEALTH SOCIETY SCIENCE TECHNOLOGY DISASTER)